Poolbeg Pharma says research confirms $10B plus opportunity for POLB 001 in cancer immunotherapies

By Proactive Investors / February 12, 2024 / www.youtube.com / Article Link

Poolbeg Pharma Plc chief business officer David Allmond joined Proactive's Stephen Gunnion with details of independent ...

Recent News

US tariff hikes shock market and drive retaliation

February 03, 2025 / www.canadianminingreport.com

Defensives and other sectors far outpace tech since H2/24

February 03, 2025 / www.canadianminingreport.com

Gold miner stock ETFs outpace rest of sector from mid-2024

January 27, 2025 / www.canadianminingreport.com

Gold stocks outpace broader equity gains

January 27, 2025 / www.canadianminingreport.com

Gold stocks rise but lag broader equity gains

January 20, 2025 / www.canadianminingreport.com

See all >